CCCC US Equity
C4 Therapeutics, Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1662579 · FY ends Dec 31$4.21
+0.03 (+0.72%)
USD · as of 2026-08-19 · marketstack
Short interest· FINRA consolidated · settlement 2026-07-31
6 settlement cycles| Shares short | 30.4M |
| % of shares out | 24.7% |
| Days to cover | 11.1 |
| Δ vs 2026-07-15 | +27.8% |
bars = shares short · line = days to cover (own scale)
| Settlement | Shares short | Δ vs prior | Avg daily volume | Days to cover |
|---|
| 2026-07-31 | 30,427,514 | +27.8% | 2,735,917 | 11.1 |
| 2026-07-15 | 23,815,010 | -4.7% | 3,579,482 | 6.7 |
| 2026-06-30 | 24,997,175 | +12.4% | 4,757,093 | 5.3 |
| 2026-06-15 | 22,246,308 | +2.8% | 2,336,354 | 9.5 |
| 2026-05-29 | 21,650,001 | +1.9% | 2,295,870 | 9.4 |
| 2026-05-15 | 21,254,462 | +0.9% | 3,661,085 | 5.8 |
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
